UNSPSC 51101630: Propamidine

This classification denotes an antiprotozoal agent with the molecular formula C17H20N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G20G12V769, chemically known as 4,4-(trimethylenedioxy)dibenzamidine but generally known as propamidine, which bears US NIH Compound Identifier 64949. European Medicines Agency schedules Propamidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10095MIG. The term PROPAMIDINE is an International Non-Proprietary Name.

UNSPSC 51101630 Propamidine is a Commodity code that does not align with the state and local procurement opportunities recently tagged under it. The recent opportunities in the source—naloxone procurement, direct-to-manufacturer pharmacy initiatives, medical and first aid supplies for fire rescue, and multi-source generic pharmaceuticals—span emergency response medications, pharmacy benefit management, first responder consumables, and wholesale pharmaceutical distribution, none of which involve propamidine as a procurement item. Propamidine is a topical antibiotic and antiseptic agent used in ophthalmic and dermatological applications; the recent solicitations do not reference it by name or as a line item, and no state or local government purchases of propamidine appear in the opportunity records.

The code shows little relevant recent activity. State and local procurement professionals evaluating this code should verify current tagging practices with issuing bodies, as the mismatch between the code's nominal scope and recent solicitation activity suggests either a classification error in the opportunity records or limited present demand for propamidine through state and local competitive procurement channels. The opportunities listed—Seminole County's naloxone and drug deactivation systems IFB, Texas HHS's therapeutic pharmacy RFI, Tampa's medical and first aid supplies IFB, and Minnesota MMCAP's multi-source pharmaceuticals RFP—represent active procurement in adjacent pharmaceutical and medical supply categories but do not constitute activity under this Commodity code itself.